A Phase I Clinical Trial to Evaluate CU-10101 Unguent

NCT06744569 · clinicaltrials.gov ↗

PHASE1

Phase

ENROLLING_BY_INVITATION

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: CU-10101

Sponsor

Cutia Therapeutics（Wuxi）Co.,Ltd